Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Goodman

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Neurologic Clinics|March 29, 2011
Symptomatic management in multiple sclerosisLawrence M Samkoff, Andrew D Goodman
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2012
Enhancing neural transmission in multiple sclerosis (4-aminopyridine therapy)Andrew D Goodman, Robert Thompson Stone
Neurology|January 10, 2002
Infections and MS: clinical trials move to center stageAndrew D Goodman, David H Miller
Expert Opinion on Investigational Drugs|October 12, 2019
Siponimod in the treatment of multiple sclerosisAndrew D Goodman, Nidhiben Anadani, Lee Gerwitz
Expert Opinion on Investigational Drugs|August 9, 2016
Ibudilast for the treatment of multiple sclerosisAndrew D Goodman, Tirisham Gyang, Andrew D Smith
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 15, 2018
Novel computer-based testing shows multi-domain cognitive dysfunction in patients with multiple sclerosisAndrew D Smith, Charles Duffy, Andrew D Goodman
Multiple Sclerosis and Related Disorders|September 1, 2019
Comparison of telemedicine versus in-person visits for persons with multiple sclerosis: A randomized crossover study of feasibility, cost, and satisfactionJessica F Robb, Megan H Hyland, Andrew D Goodman
Journal of Rehabilitation Research and Development|June 8, 2002
Fatigue in multiple sclerosis: current understanding and future directionsSteven R Schwid, Melissa Covington, Benjamin M Segal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
A randomized trial of memantine as treatment for spasticity in multiple sclerosisLahar R Mehta, Michael P McDermott, Andrew D Goodman, et al.
Neurology|May 11, 2016
Fingolimod-associated PML in a patient with prior immunosuppressionTirisham V Gyang, Johanna Hamel, Andrew D Goodman, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Neurologic Clinics|March 29, 2011
Symptomatic management in multiple sclerosisLawrence M Samkoff, Andrew D Goodman
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2012
Enhancing neural transmission in multiple sclerosis (4-aminopyridine therapy)Andrew D Goodman, Robert Thompson Stone
Neurology|January 10, 2002
Infections and MS: clinical trials move to center stageAndrew D Goodman, David H Miller
Expert Opinion on Investigational Drugs|October 12, 2019
Siponimod in the treatment of multiple sclerosisAndrew D Goodman, Nidhiben Anadani, Lee Gerwitz
Expert Opinion on Investigational Drugs|August 9, 2016
Ibudilast for the treatment of multiple sclerosisAndrew D Goodman, Tirisham Gyang, Andrew D Smith
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 15, 2018
Novel computer-based testing shows multi-domain cognitive dysfunction in patients with multiple sclerosisAndrew D Smith, Charles Duffy, Andrew D Goodman
Multiple Sclerosis and Related Disorders|September 1, 2019
Comparison of telemedicine versus in-person visits for persons with multiple sclerosis: A randomized crossover study of feasibility, cost, and satisfactionJessica F Robb, Megan H Hyland, Andrew D Goodman
Journal of Rehabilitation Research and Development|June 8, 2002
Fatigue in multiple sclerosis: current understanding and future directionsSteven R Schwid, Melissa Covington, Benjamin M Segal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
A randomized trial of memantine as treatment for spasticity in multiple sclerosisLahar R Mehta, Michael P McDermott, Andrew D Goodman, et al.
Neurology|May 11, 2016
Fingolimod-associated PML in a patient with prior immunosuppressionTirisham V Gyang, Johanna Hamel, Andrew D Goodman, et al.
Pageof 5